1. Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease
- Author
-
Tamaki, Nobuharu, Higuchi, Mayu, Kurosaki, Masayuki, Loomba, Rohit, Izumi, Namiki, Group, MRCH Liver Study, Inada, Kento, Kirino, Sakura, Yamashita, Koji, Sekiguchi, Shuhei, Hayakawa, Yuka, Osawa, Leona, Takaura, Kenta, Maeyashiki, Chiaki, Kaneko, Shun, Yasui, Yutaka, Takahashi, Yuka, Tsuchiya, Kaoru, Nakanishi, Hiroyuki, and Itakura, Jun
- Subjects
Liver Cancer ,Rare Diseases ,Prevention ,Chronic Liver Disease and Cirrhosis ,Heart Disease ,Cancer ,Digestive Diseases ,Hepatitis ,Liver Disease ,Cardiovascular ,Oral and gastrointestinal ,Good Health and Well Being ,Carcinoma ,Hepatocellular ,Cardiovascular Diseases ,Humans ,Liver Cirrhosis ,Liver Neoplasms ,Non-alcoholic Fatty Liver Disease ,MRCH Liver Study Group ,Clinical Sciences ,Gastroenterology & Hepatology - Abstract
Nonalcoholic fatty liver disease (NAFLD) has affected more than one-fourth of the global population, thus emerging as a worldwide health and economic burden.1 The common causes of death in patients with NAFLD include cardiovascular disease (CVD), decompensation, and hepatocellular carcinoma (HCC). However, identifying the risk of these complications in patients with NAFLD remains an unmet need in clinical practice.
- Published
- 2022